80 related articles for article (PubMed ID: 17972953)
1. Downregulation of microRNA-142 by proto-oncogene LMO2 and its co-factors.
Yuan W; Sun W; Yang S; Du J; Zhai CL; Wang ZQ; Zhang J; Zhu TH
Leukemia; 2008 May; 22(5):1067-71. PubMed ID: 17972953
[No Abstract] [Full Text] [Related]
2. Monoallelic or biallelic LMO2 expression in relation to the LMO2 rearrangement status in pediatric T-cell acute lymphoblastic leukemia.
Van Vlierberghe P; Beverloo HB; Buijs-Gladdines J; van Wering ER; Horstmann M; Pieters R; Meijerink JP
Leukemia; 2008 Jul; 22(7):1434-7. PubMed ID: 18079736
[No Abstract] [Full Text] [Related]
3. The E2A-HLF oncogenic fusion protein acts through Lmo2 and Bcl-2 to immortalize hematopoietic progenitors.
de Boer J; Yeung J; Ellu J; Ramanujachar R; Bornhauser B; Solarska O; Hubank M; Williams O; Brady HJ
Leukemia; 2011 Feb; 25(2):321-30. PubMed ID: 21072044
[TBL] [Abstract][Full Text] [Related]
4. Chromosomal translocations and leukaemia: a role for LMO2 in T cell acute leukaemia, in transcription and in erythropoiesis.
Rabbitts TH; Axelson H; Forster A; Grutz G; Lavenir I; Larson R; Osada H; Valge-Archer V; Wadman I; Warren A
Leukemia; 1997 Apr; 11 Suppl 3():271-2. PubMed ID: 9209362
[TBL] [Abstract][Full Text] [Related]
5. Ectopic retroviral expression of LMO2, but not IL2Rgamma, blocks human T-cell development from CD34+ cells: implications for leukemogenesis in gene therapy.
Pike-Overzet K; de Ridder D; Weerkamp F; Baert MR; Verstegen MM; Brugman MH; Howe SJ; Reinders MJ; Thrasher AJ; Wagemaker G; van Dongen JJ; Staal FJ
Leukemia; 2007 Apr; 21(4):754-63. PubMed ID: 17268520
[TBL] [Abstract][Full Text] [Related]
6. LIM-only protein Lmo2 forms a protein complex with erythroid transcription factor GATA-1.
Osada H; Grutz GG; Axelson H; Forster A; Rabbitts TH
Leukemia; 1997 Apr; 11 Suppl 3():307-12. PubMed ID: 9209374
[TBL] [Abstract][Full Text] [Related]
7. Assembly of the oncogenic DNA-binding complex LMO2-Ldb1-TAL1-E12.
Ryan DP; Duncan JL; Lee C; Kuchel PW; Matthews JM
Proteins; 2008 Mar; 70(4):1461-74. PubMed ID: 17910069
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA 223-dependent expression of LMO2 regulates normal erythropoiesis.
Felli N; Pedini F; Romania P; Biffoni M; Morsilli O; Castelli G; Santoro S; Chicarella S; Sorrentino A; Peschle C; Marziali G
Haematologica; 2009 Apr; 94(4):479-86. PubMed ID: 19278969
[TBL] [Abstract][Full Text] [Related]
9. Regulation of LMO2 mRNA and protein expression in erythroid differentiation.
Brandt SJ; Koury MJ
Haematologica; 2009 Apr; 94(4):447-8. PubMed ID: 19336746
[TBL] [Abstract][Full Text] [Related]
10. A postulated role for transcriptional regulator LMO2 in the proliferation and involution of hemangioma.
Sun ZJ; Zhang L; Zhao YF
Med Hypotheses; 2006; 67(5):1230-2. PubMed ID: 16793212
[TBL] [Abstract][Full Text] [Related]
11. The role of LMO2 in development and in T cell leukemia after chromosomal translocation or retroviral insertion.
Nam CH; Rabbitts TH
Mol Ther; 2006 Jan; 13(1):15-25. PubMed ID: 16260184
[TBL] [Abstract][Full Text] [Related]
12. miR-223 and miR-142 attenuate hematopoietic cell proliferation, and miR-223 positively regulates miR-142 through LMO2 isoforms and CEBP-β.
Sun W; Shen W; Yang S; Hu F; Li H; Zhu TH
Cell Res; 2010 Oct; 20(10):1158-69. PubMed ID: 20856265
[TBL] [Abstract][Full Text] [Related]
13. Targeting LMO2 with a peptide aptamer establishes a necessary function in overt T-cell neoplasia.
Appert A; Nam CH; Lobato N; Priego E; Miguel RN; Blundell T; Drynan L; Sewell H; Tanaka T; Rabbitts T
Cancer Res; 2009 Jun; 69(11):4784-90. PubMed ID: 19487290
[TBL] [Abstract][Full Text] [Related]
14. An experimental system for the evaluation of retroviral vector design to diminish the risk for proto-oncogene activation.
Ryu BY; Evans-Galea MV; Gray JT; Bodine DM; Persons DA; Nienhuis AW
Blood; 2008 Feb; 111(4):1866-75. PubMed ID: 17991809
[TBL] [Abstract][Full Text] [Related]
15. Identification of the LMO4 gene encoding an interaction partner of the LIM-binding protein LDB1/NLI1: a candidate for displacement by LMO proteins in T cell acute leukaemia.
Grutz G; Forster A; Rabbitts TH
Oncogene; 1998 Nov; 17(21):2799-803. PubMed ID: 9840944
[TBL] [Abstract][Full Text] [Related]
16. LMO2 protein expression predicts survival in patients with rheumatoid arthritis and diffuse large B-cell lymphoma.
Baecklund E; Backlin C; Mansouri M; Klareskog L; Askling J; Iliadou AN; Enblad G; Lossos IS; Natkunam Y; Rosenquist R
Leuk Lymphoma; 2011 Jun; 52(6):1146-9. PubMed ID: 21375434
[No Abstract] [Full Text] [Related]
17. Single domain intracellular antibodies from diverse libraries: emphasizing dual functions of LMO2 protein interactions using a single VH domain.
Tanaka T; Sewell H; Waters S; Phillips SE; Rabbitts TH
J Biol Chem; 2011 Feb; 286(5):3707-16. PubMed ID: 20980262
[TBL] [Abstract][Full Text] [Related]
18. The oncogenic cysteine-rich LIM domain protein rbtn2 is essential for erythroid development.
Warren AJ; Colledge WH; Carlton MB; Evans MJ; Smith AJ; Rabbitts TH
Cell; 1994 Jul; 78(1):45-57. PubMed ID: 8033210
[TBL] [Abstract][Full Text] [Related]
19. Novel non-TCR chromosome translocations t(3;11)(q25;p13) and t(X;11)(q25;p13) activating LMO2 by juxtaposition with MBNL1 and STAG2.
Chen S; Nagel S; Schneider B; Kaufmann M; Meyer C; Zaborski M; Kees UR; Drexler HG; MacLeod RA
Leukemia; 2011 Oct; 25(10):1632-5. PubMed ID: 21647158
[No Abstract] [Full Text] [Related]
20. TAL-1/SCL and its partners E47 and LMO2 up-regulate VE-cadherin expression in endothelial cells.
Deleuze V; Chalhoub E; El-Hajj R; Dohet C; Le Clech M; Couraud PO; Huber P; Mathieu D
Mol Cell Biol; 2007 Apr; 27(7):2687-97. PubMed ID: 17242194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]